You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.

03 August 2017

Injectable antiretroviral drugs – a ‘remarkable milestone’

Long-lasting antiretroviral drugs injected monthly present a ‘remarkable milestone’ in treatment options for people living with HIV

0
20 July 2017

HIV drug resistance is rising and needs urgent attention, says World Health Organization

Without urgent action, HIV drug resistance is set to derail the HIV response and presents a significant threat to public health, the World Health Organization (WHO) warns today.

0
21 February 2017

Pre-treatment drug resistance as high as 17% with no impact on viral load suppression

‘Surprising’ research from Conference on Retroviruses and Opportunistic Infections (CROI) shows drug resistance does not impact test-and-treat roll-out in South Africa – at least in the short term.

0
19 January 2017

Rural and urban patterns of HIV drug resistance in South Africa

HIV is more proactively monitored among urban HIV patients than rural patients, and drug resistance and treatment failure is less prevalent. However outcomes for second line treatment remain similar.

0
11 January 2017

Interventions to keep people in HIV care more cost-effective than a ‘treat all’ approach

Treatment scale-up has had major public health benefits. But where resources are scarce, interventions to keep people in care could be more cost-effective than moving to treat everybody living with HIV after diagnosis.

0
06 December 2016

India reaches 1 million people on treatment

The world’s second largest antiretroviral treatment programme is now reaching just under half of all those living with HIV in India, but challenges remain to achieve UNAIDS’ 90-90-90 Fast-Track targets.

0
09 November 2016

Venezuelan AIDS-deaths double in five years amid mounting health crisis

Concerns have been raised about the shortage of antiretroviral drugs available for people living with HIV in Venezuela, which is in the midst of a mounting health crisis.

0
05 February 2016

Analysis: Tenofovir resistance ‘surprisingly common’

Resistance to the commonly prescribed antiretroviral drug tenofovir is ‘surprisingly common’, according to findings published in the Lancet Infectious Diseases last week. 

0